Suppr超能文献

不同制造商的人工耳蜗再植入后的表现。

Performance After Cochlear Reimplantation Using a Different Manufacturer.

机构信息

Department of Otolaryngology-Head and Neck Surgery, NYU Langone, New York, New York.

Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa.

出版信息

Otol Neurotol. 2024 Oct 1;45(9):1016-1022. doi: 10.1097/MAO.0000000000004314.

Abstract

OBJECTIVE

To better understand cochlear implant (CI) performance after reimplantation with a different device manufacturer.

STUDY DESIGN

Multisite retrospective review.

SETTING

Tertiary referral centers.

PATIENTS

Patients older than 4 years who received a CI and subsequently underwent CI reimplantation with a different manufacturer over a 20-year period.

INTERVENTION

Reimplantation.

MAIN OUTCOME MEASURE

The primary outcome was difference in the best CNC score obtained with the primary CI, compared with the most recent CNC score obtained after reimplantation.

RESULTS

Twenty-nine patients met the criteria at three centers. The best average CNC score achieved by adult patients after primary cochlear implantation was 46.2% (n = 16), measured an average of 14 months (range: 3-36 mo) postoperatively. When looking at the most recent CNC score of adult patients before undergoing reimplantation, the average CNC score dropped to 19.2% (n = 17). After reimplantation, the average 3- to 6-month CNC score was 48.3% (n = 12), with most recent average CNC score being 44.4% (n = 17) measured an average of 19 months (range: 3-46 mo) postoperatively. There was no statistically significant difference (p = 0.321; t11 = 0.48) identified in performance between the best CNC score achieved by adult patients after primary cochlear implantation, and the most recent score achieved after reimplantation (n = 12). Analysis of prerevision and postrevision speech performance was not possible in pediatric patients (<18 yr old) because of differences in tests administered.

CONCLUSION

Patients undergoing reimplantation with a different manufacturer achieved CNC score performance comparable to their best performance with their original device.

摘要

目的

更好地了解不同设备制造商的人工耳蜗(CI)再植入后的性能。

研究设计

多地点回顾性研究。

设置

三级转诊中心。

患者

4 岁以上接受 CI 植入并在 20 年内接受不同制造商的 CI 再植入的患者。

干预

再植入。

主要观察指标

主要结果是使用原设备获得的最佳 CNC 评分与再植入后最近获得的 CNC 评分之间的差异。

结果

在三个中心有 29 名患者符合标准。成人患者在初次耳蜗植入后获得的最佳平均 CNC 评分是 46.2%(n=16),平均术后 14 个月(范围:3-36 个月)测量。当查看成人患者在接受再植入前的最近 CNC 评分时,平均 CNC 评分降至 19.2%(n=17)。再植入后,3-6 个月的平均 CNC 评分为 48.3%(n=12),最近的平均 CNC 评分为 44.4%(n=17),平均术后 19 个月(范围:3-46 个月)测量。在初次耳蜗植入后成年患者获得的最佳 CNC 评分与再植入后最近获得的评分(n=12)之间,未发现统计学上的显著差异(p=0.321;t11=0.48)。由于所进行的测试不同,无法对儿科患者(<18 岁)进行术前和术后言语表现的分析。

结论

接受不同制造商再植入的患者获得的 CNC 评分表现与他们使用原始设备获得的最佳表现相当。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验